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A Caenorhabditis elegans ORF encoding the presumptive condens-
ing enzyme activity of a fatty acid elongase has been characterized
functionally by heterologous expression in yeast. This ORF
(F56H11.4) shows low similarity to Saccharomyces cerevisiae genes
involved in fatty acid elongation. The substrate specificity of the C.
elegans enzyme indicated a preference for D6-desaturated C18
polyunsaturated fatty acids. Coexpression of this activity with
fatty acid desaturases required for the synthesis of C20 polyun-
saturated fatty acids resulted in the accumulation of arachidonic
acid from linoleic acid and eicosapentaenoic acid from a-linolenic
acid. These results demonstrate the reconstitution of the n-3 and
n-6 polyunsaturated fatty acid biosynthetic pathways. The C.
elegans ORF is likely to interact with endogenous components of
a yeast elongation system, with the heterologous nematode con-
densing enzyme F56H11.4 causing a redirection of enzymatic
activity toward polyunsaturated C18 fatty acid substrates.
Unsaturated fatty acids are essential components required fornormal cellular function, being involved in roles ranging from
membrane fluidity to acting as signal molecules (1, 2). In particular,
the class of fatty acids known as the polyunsaturated fatty acids
(PUFAs) has attracted considerable interest as pharmaceutical and
nutraceutical compounds (2, 3). PUFAs can be defined as fatty
acids of 18 carbons or more in length, containing two or more
double bonds. These double bonds are inserted by specific fatty acid
desaturase enzymes that have been the subject of intense research
in recent years (4, 5). The PUFAs can be classified into two groups,
n-6 or n-3, depending on the position (n) of the double bond nearest
the methyl end of the fatty acid (1, 2, 5). Thus, g-linolenic acid
(18:3D6,9,12) is classified as an 18:3, n-6 PUFA, whereas a-linolenic
acid (18:3D9,12,15) is an 18:3, n-3 PUFA. Many PUFAs are also
essential fatty acids, being required in the diet for normal devel-
opment in mammals that cannot synthesize the primary essential
fatty acid-PUFA linoleic acid (18:2, n-6; ref. 2). More recently,
interest has focused on the C20 fatty acid arachidonic acid (20:4,
n-6), which has been shown to be involved in neonatal health,
including retinal and brain development (6).
C20 fatty acids such as 20:4, n-6 are synthesized by sequential
desaturation, elongation, and further desaturation of dietary
18:2, n-6 (2, 5), and a schematic representing a generalized
pathway for PUFA synthesis is shown in Fig. 1. Although the two
desaturases (D6- and D5-fatty acid desaturases) required for this
pathway have been cloned recently from a number of different
sources (7–14), no genes have been characterized for the C2
elongation of the C18 PUFA. Biochemical characterization of
mammalian elongation systems (most notably from liver micro-
somes) has indicated that the ‘‘elongase’’ actually consists of four
enzyme activities, being made up of a condensing enzyme, a
b-ketoreductase, a dehydrase, and an enoyl reductase (reviewed
in ref. 15). In higher plants, the FAE1 (fatty acid elongation 1)
gene from Arabidopsis thaliana is required for the accumulation
of the monounsaturated C22 fatty acid erucic acid (22:1, n-9; ref.
16). The FAE1 gene product is predicted to have a condensing
enzyme activity, and the deduced amino acid sequence shows
some limited similarity to other condensing enzymes such as
chalcone synthase and stilbene synthase (16). Although FAE1 is
normally expressed only in seed tissues, ectopic expression of
FAE1 in nonseed tissue (or heterologous expression in yeast)
resulted in the accumulation of erucic acid (17).
To reconstitute the long-chain PUFA biosynthetic pathway in
a heterologous host such as yeast, it was necessary to identify
enzymes involved in PUFA elongation. Previously, we and
others (18, 19) have observed a high degree of similarity between
the D6-fatty acid desaturase (responsible for the first step in
PUFA synthesis by the desaturation of 18:2, n-6) and a desatu-
rase that introduces double bonds into the long-chain base of
sphingolipids. We reasoned that the relationship between fatty
acid and sphingolipid modification might also extend to the
elongation reaction. Two yeast genes (ELO2 and ELO3) in-
volved in the formation of the very long-chain saturated fatty
acid moiety of sphingolipids have been characterized at the
genetic and biochemical levels (20). We therefore used con-
served motifs contained within these ELO genes to identify
potential ORFs encoding enzymes involved in fatty acid elon-
gation in the PUFA-accumulating organism Caenorhabditis el-
egans, which has also been the subject of a completed genome
sequencing program (21). These ORFs were characterized func-
tionally by heterologous expression in yeast, allowing the iden-
tification of activities involved in PUFA elongation.
Materials and Methods
Identification of C. elegans ORFs of Interest. The C. elegans genome
sequence was searched for sequences related to the yeast ELO2y3
genes via the BLAST suite of programs by using those yeast ORFs
as search templates (http:yywww.sanger.ac.ukyProjectsyCoelegansy
blastoserver.shtml). The conserved motifs H-X-X-H-H and M-Y-
X-Y-Y were also used in conjunction with the ELO2y3 ORFs to
search databases with PHI-BLAST. PCR primers were designed to
amplify the predicted ORFs of interest with cDNA purified from
a C. elegans N2 mixed-stage library used as a template, according
to previously described methods (8, 12). PCR amplification was
carried out with standard protocols (7, 8, 10, 12).
Cloning of Desaturase and Elongase Genes in Yeast Expression Vectors. C.
elegans ORFs F56H11.4 and F41H10.8 were cloned by PCR into the
pYES2 vector (Invitrogen). F56H11.4 was amplified with primers
56h114.for (59-GCGGGTACCATGGCTCAGCATCCGCTC-39)
and 56h114.rev (59-GCGGGATCCTTAGTTGTTCTTCTTCTT-
39), and F41H10.8 was amplified with primers 41h108.for (59-
GCGGGTACCATGCCACAGGGAGAAGTC-39) and
41h108.rev (59-GCGGGATCCTTATTCAATTTTTCTTTT-39).
Amplified sequences were then restricted with KpnI and BamHI
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(underlined in the forward and reverse primers, respectively),
purified with the Qiagen PCR purification kit (Chatsworth, CA),
and ligated into a KpnIyBamHI-cut pYes2. An ORF encoding the
Mortierella alpina D5-fatty acid desaturase (10) was amplified with
primers Mad5.for (59-GCGAATTCACCATGGGTACGGAC-
CAAGGA-39) and Mad5.rev (59GCGGAGCTCCTACTCTTC-
CTTGGGACG-39), restricted with EcoRI and SacI, gel purified as
described (10), and ligated into a EcoRIySacI-cut pESC-TRP
vector (Stratagene) to generate pESCyD5. An ORF encoding the
borage D6-fatty acid desaturase (7) was restricted from pGEM3
with BamHI and XhoI and ligated into a BamHIyXhoI-cut pESC-
TRP vector to generate pESCyD6. A double construct was also
generated by ligating the BamHIyXhoI borage D6 insert into the
pESCyD5 construct described above, generating pESCy(D5,D6). All
PCR amplifications were carried out under standard conditions (7).
Functional Characterization in Yeast. ORFs encoding putative elon-
gation activities and desaturase constructs were introduced in
Saccharomyces cerevisiae W303-1A by using a lithium acetate-
based method, and expression of the transgenes was induced by
addition of galactose to 2% (wtyvol) as described (8, 10, 12).
Yeast transformants containing pYES2-derived constructs were
grown on synthetic dextrose minimal medium minus uracil;
pESC-derived constructs were grown on synthetic dextrose
minimal medium minus tryptophan. Cotransformed yeast (con-
taining both pYES2 and pESC derivatives) was grown on
synthetic dextrose minimal medium minus uracil and trypto-
phan. Before induction, cultures were grown at 22°C with
shaking in the presence of 2% (volyvol) raffinose and supple-
mented with 0.5 mM of appropriate fatty acid substrate in the
presence of 1% tergitol-Nonidet P-40 (Sigma). All cultures were
then grown for a further 48 h unless indicated. All analysis was
performed on triplicate samples and replicated three times.
Fatty Acid Analysis. Total fatty acids extracted from yeast cultures
were analyzed by GC of methyl ester derivatives. Lipids were
extracted and transmethylated with methanolic HCl, and the
fatty acid methyl esters were analyzed as described (7, 8, 10).
GC-MS Analysis. Identification of induced peaks was carried out by
coinjection with known standards (such as 20:3, n-6; 20:4, n-6;
etc.), followed by characterization via GC-MS (Kratos Analyt-
ical Instruments MS80RFA) operating at an ionization voltage
of 70 eV with a scan range of 40–500 Da, as described (8, 10, 12).
Results
The entire C. elegans genome was searched for ORFs that showed low
levels of similarity to the yeast ELO genes, so as to identify related
sequences or paralogues rather than actual homologues. A number of
C. elegans ORFs were identified by this search and then subjected to
functional characterization by heterologous expression of the appro-
priate cDNA in yeast. Previously, we have used this method successfully
to identify a number of fatty acid desaturases from organisms including
C. elegans (8, 12). PCR was used to amplify the coding sequence of the
ORFs of interest by using a C. elegans mixed-stage cDNA library as a
template. To identify the elongation reaction responsible for the syn-
thesis of di-homo-g-linolenic acid (20:3, n-6) from 18:3, n-6, ORFs were
expressed in the presence of this (exogenous) substrate. One cDNA
ORF tested in this manner displayed a high level of elongation activity
on the 18:3, n-6 substrate, converting 44% to 20:3, n-6 (Fig. 2). The
identity of this elongation product was confirmed by GC comparison
with a known standard, followed by GC-MS analysis. The DNA
sequence and deduced amino acid sequence of this functional clone
identified it as being encoded by the C. elegans gene F56H11.4. Fig. 3
indicates that, when compared with the deduced amino acid sequence
of the yeast ELO genes, similarity was confined to a few short amino
acid motifs. It was also clear that the deduced amino acid sequence of
F56H11.4 (288 amino acid residues) showed no similarity to any
Fig. 1. Scheme representing the biosynthesis of PUFAs in animals. Primary n-6 and n-3 fatty acids (in the form of linoleic and a-linolenic acid) must be provided
from dietary intake because of an inability to desaturate oleic acid further. The enzyme activities required for this pathway are shown.






















previously described condensing enzymes (e.g., FAE1 or chalcone
synthase). F56H11.4 does not contain the putative NADPH-binding
site initially identified in the yeast ELO1 gene product (ref. 22; which
is also absent in ELO2y3; ref. 20) and seems to contain multiple
membrane-spanning domains. The protein is likely to be located (and
retained) in the endoplasmic reticulum, as indicated by the presence of
a C-terminal dilysine retention signal. We also observed some similarity
with a mouse gene, Cig30 (23), which has been implicated in the
recruitment of brown adipose tissue in liver tissue, as well as a potential
human homologue encoded by a gene located on chromosome 4q25,
bacterial artificial chromosome 207d4 (Fig. 3).
The range of fatty acids synthesized by C. elegans may require a
number of different elongation reactions (24). We therefore de-
termined the substrate specificity of the F56H11.4 activity by using
a range of exogenously supplied fatty acids. This determination
revealed (Table 1) that 18:3, n-6 is the major substrate, with a
number of other fatty acids being elongated at a lower efficiency.
Although most of these substrates are PUFAs, we were surprised
to observe the (F56H11.4-directed) elongation of palmitoleic acid
(16:1, n-7) to vaccenic acid (18:1, n-7). The biosynthetic pathway for
18:1, n-7 is unclear, but our data indicate that it may be synthesized
by elongation of D9-monounsaturated C16 fatty acid. In some
treatments, decreased levels of monounsaturated fatty acids re-
sulted from the addition of exogenous C18 PUFAs, via their
previously documented metabolic repression of the OLE1 D9-fatty
acid desaturase (25). We also observed that, although expression of
F56H11.4 conferred the ability to elongate C18 PUFAs, this ability
was not observed for C20 PUFAs, even though C20 PUFAs are
readily taken up yeast (10, 12).
The C. elegans ORF F56H11.4 is located on chromosome IV at
4.32 centimorgans, with a related sequence (F56H11.3; 51% sim-
ilarity) 1,824 bp downstream. We also observed another C. elegans
gene (F41H10.8), also present on chromosome IV, which shows a
slightly higher level (53%) of similarity to F56H11.4 (Fig. 3).
However, when a PCR product encoding ORF F41H10.8 was
expressed in yeast in a manner identical to that used for F56H11.4,
the former failed to direct the elongation of any fatty acids, despite
the provision of a range of substrates (data not shown).
To reconstitute the PUFA biosynthetic pathway in a heterolo-
gous system, we expressed the PUFA elongating activity F56H11.4
in yeast in conjunction with either the D6- or D5-fatty acid desatu-
rases previously isolated and characterized by our group (8, 12).
Expression of the D6-fatty acid desaturase and F56H11.4 was
carried out in the presence of two different substrates (18:2, n-6 or
18:3, n-3), but the D5-fatty acid desaturase and the elongase were
expressed in the presence of 18:3, n-6 only. The results shown in
Table 2 indicated that it was possible to combine a desaturase and
an elongation activity in yeast to generate significant amounts of
final ‘‘product.’’ In the case of F56H11.4 and the D6-fatty acid
desaturase, the reactions proved highly efficient with the produc-
tion of 4.5% of 20:3, n-6 from the 18:2, n-6 substrate; 25% of the
18:2, n-6 substrate was desaturated to 18:3, n-6, which was then
elongated to 20:3, n-6 at a similar level of efficiency (18%). This
elongation efficiency is lower than the percentage conversion
observed for 18:3, n-6 when supplied exogenously (Table 1),
indicating that in vivo production (as opposed to exogenous sup-
plementation) of substrates for elongation may be rate-limiting. If
18:3, n-3 was used as a substrate, 27% was initially D6-desaturated
to yield octadecatetraenoic acid (18:4, n-3), but only 8% was
elongated subsequently to yield eicosatetraenoic acid (20:4, n-3).
Thus, the conversion efficiency of 18:3, n-3 to the final C20
tetraenoic PUFA was only about 2.2%. These data indicate that the
reconstituted elongase activity is capable of accepting both forms
(n-6 and n-3) of essential fatty acid, although with slightly different
efficiencies. We also verified that the C20 PUFAs synthesized in our
yeast expression system were generated by the D6-desaturation of
C18 substrates, which were elongated subsequently, because the
D6-desaturase showed no activity on 20:2, n-6 or 20:3, n-3 substrates
(Table 2). The combination of the D5-desaturase and F56H11.4 also
demonstrated that these two enzymes could work in tandem,
although the efficiency of this overall conversion was low (3.3%
20:4, n-6 from 18:3, n-6) because of the previously observed low
activity of the D5-desaturase enzyme (10, 12). Thus, although nearly
45% of the 18:3, n-6 substrate was elongated to 20:3, n-6, only 7.5%
was subsequently desaturated to 20:4, n-6 (Table 2).
Finally, the production of either 20:4, n-6 or eicosapentaenoic
acid (20:5, n-3) yeast from dienoic or trienoic C18 substrates was
achieved via expression of all three enzymes (the two desaturases
and the F56H11.4 PUFA elongating activity simultaneously. As
shown in Table 3, small but significant amounts of 20:4, n-6 were
produced when the yeast was supplied with the dienoic substrate
18:2, n-6. The identity of this C20 PUFA was verified by GC-MS,
indicating that the conversion efficiency of 18:2, n-6 to 20:4, n-6 was
0.65%. When 18:3, n-3 was used as a substrate, 12.5% of the
Fig. 2. Identification of fatty acid elongation activity in yeast expressing a C.
elegans ORF. Chromatograms of fatty acid methyl esters from yeast trans-
formed with the control (empty) plasmid pYES2 (A) or with ORF F56H11.4 in
pYES2 (B). Exogenous substrate in the form of 18:3, n-6 (annotated as 18:3)
was supplied to the cultures. Two additional peaks are observed in B; these
peaks were identified (against known standards) as 20:3, n-6 and 18:1, n-7 and
are annotated in B as 20:3 and 18:1* (in the latter case, this annotation is to
distinguish this 18:1, n-7 fatty acid from 18:1, n-9). Detection was by flame
ionization, with peak identification by subsequent GC-MS.





























(D6-desaturated and elongated) 20:4, n-3 fatty acid was D5-
desaturated, resulting in a total conversion of 0.3% of the substrate
18:3, n-3 to 20:5, n-3 (the identity of which was also confirmed by
GC-MS).
Discussion
We have identified a C. elegans ORF F56H11.4 that is capable
of directing the C2 elongation of g-linolenic acid when heter-
ologously expressed in yeast. The expression of a single ORF
might not be expected to result in fatty acid elongation, because
it is generally considered that the elongation activity consists of
four distinct enzymes (15), and it is highly unlikely that all four
activities are contained within a single polypeptide. Therefore,
the ‘‘elongase’’ activity observed with the expression of
F56H11.4 in yeast is likely to arise from an interaction with other
endogenous components of a yeast elongase (which presump-
tively would interact normally with the ELO gene products).
Interestingly, expression of the Arabidopsis FAE1 ORF in yeast
results in the accumulation of very long-chain monounsaturated
fatty acids (via the elongation of C18:1; ref. 17). The authors
considered it likely that FAE1 (encoding the condensing enzyme
subunit of the elongase) was able to interact with endogenous
reductases and dehydrase to form a functional elongase complex
(17). Whether FAE1 and F56H11.4 reconstitute their distinct
elongase activities by interacting with common yeast compo-
nents is an interesting (but open) question. The C. elegans ORF
described in the present study does not show any similarity to
FAE1, even over short domains, although FAE1 shows some
limited similarity to other condensing enzymes. In fact, the only
obvious motifs present in F56H11.4 are a ‘‘histidine box’’ nor-
mally found in enzymes such as desaturases (4), several con-
served tyrosine residues, and a potential C-terminal endoplasmic
reticulum-retentionyrecycling motif. In view of the presence of
a number of predicted transmembrane domains in F56H11.4, it
Fig. 3. Comparison of C. elegans ORF F56H11.4 with related sequences. The entire coding sequence of F56H11.4 (accession no. Z68749) was compared with
the S. cerevisiae ELO ORFs (ELO1, Z49471; ELO2, CAA42301; ELO3, AAC28398) and a related mouse gene, Cig30 (U97107). The most closely related C. elegans
ORFs, F41H10.8 (U61954) and F56H11.3 (Z68749) are also shown, as is part of a related human gene from chromosome IV (present on bacterial artificial
chromosome clone B207d4; AC004050). The GenBank accession numbers are given for all sequences.






















is probable that this ORF encodes an integral (endo)membrane
protein, which is in good agreement with previous biochemical
studies on mammalian elongases (15). Although, intuitively, it
seems likely that C. elegans ORF F56H11.4 encodes a condens-
ing enzyme, this likelihood awaits biochemical confirmation.
The lack of similarity with previously described condensing
Table 1. Fatty acid composition of yeast expressing C. elegans ORF F56H11.4
Fatty acid
mol percentage of fatty acids
Control
(pYES2) F56H11.4
2 2 18:3, n-6 18:2, n-6 18:3, n-3 20:5, n-3
2 1 2 1 2 1 2 1 2 1 2
16:0 17.5 6 3.3 19.9 6 3.5 20.5 6 4.1 27.7 6 1.4 29.8 6 0.2 22.9 6 1.5 23.9 6 1.0 19.1 6 0.7 20.2 6 1.1 23.4 6 0.2 24.2 6 1.0
16:1, n-7 53.2 6 7.2 40.9 6 3.1 49.4 6 3.2 32.5 6 4.4 34.4 6 1.8 21.2 6 2.2 24.8 6 4.9 18.1 6 1.5 19.6 6 2.5 26.9 6 0.7 34.5 6 1.5
18:0 4.5 6 0.7 4.7 6 0.9 4.9 6 0.5 5.6 6 0.5 5.6 6 0.3 5.1 6 0.3 4.4 6 0.1 5.0 6 0.3 4.5 6 0.1 5.3 6 0.2 5.4 6 0.2
18:1, n-9 24.8 6 3.9 24.9 6 1.4 25.2 6 2.3 16.9 6 0.9 16.1 6 0.3 11.2 6 2.4 10.7 6 1.5 10.1 6 1.1 9.9 6 1.2 15.4 6 0.4 17.8 6 1.1
18:1, n-7 — 9.6 6 0.6 — 3.9 6 0.6 — 3.2 6 0.6 — 3.1 6 0.4 — 6.2 6 0.3 —
18:2, n-6 — — — — — 34.4 6 4.2 36.2 6 5.6 — — — —
18:3, n-3 — — — — — — — 43.1 6 3.9 45.8 6 4.8 — —
18:3, n-6 — — — 7.5 6 1.2 14.0 6 0.3 — — — — — —
20:2, n-6 — — — — — 2.0 6 0.9 — — — — —
20:3, n-6 — — — 5.8 6 0.9 — — — — — — —
20:3, n-3 — — — — — — — 1.5 6 0.1 — — —
20:5, n-3 — — — — — — — — — 22.8 6 0.7 20.1 6 2.4
Percentage elongated
18:3, n-6 — — — 44 — — — — — — —
18:2, n-6 — — — — — 5.5 — — — — —
18:3, n-3 — — — — — — — 3.4 — — —
20:5, n-3 — — — — — — — — — 0 —
Substrate specificity of C. elegans ORF F56H11.4 expressed in yeast in the presence of different fatty acids; 18:3, n-6; 18:2, n-6; 18:3, n-3; or 20:5, n-3 fatty acids
were added to the cultures before induction with galactose. Analysis by GC of fatty acid methyl esters was carried out on either induced (1) or noninduced (2)
triplicated samples; induction time was 48 h. The fatty acid composition of control transformed yeast (empty pYES2 vector) is also indicated. All values are
expressed as mol percentage of total fatty acids. Standard deviations are given (n 5 4), as is the percentage elongation of different substrates.
Table 2. Fatty acid composition of yeast coexpressing C. elegans ORF F56H11.4 and a fatty acid desaturase
Fatty acid
mol percentage of fatty acids
D6 F56H11.4 1 D6 F56H11.4 1 D5
20:2, n-6 20:3, n-3 18:2, n-6 18:3, n-3 18:3, n-6
1 2 1 2 1 2 1 2
16:0 24.7 6 1.3 25.2 6 1.5 18.7 6 0.6 23.7 6 0.5 17.4 6 0.7 21.0 6 1.3 27.9 6 4.2 29.8 6 3.8
16:1, n-7 46.0 6 2.8 43.7 6 3.7 18.9 6 1.2 24.6 6 0.7 5.3 6 0.6 9.1 6 0.9 24.6 6 3.4 25.1 6 3.2
16:2, n-7 5.2 6 1.2 4.1 6 1.4 0.6 6 0.1 — 0.4 6 0.1 — — —
18:0 4.8 6 0.4 5.1 6 0.4 4.0 6 0.3 5.1 6 0.1 6.2 6 0.7 5.4 6 0.2 5.6 6 0.8 5.4 6 0.7
18:1, n-9 15.3 6 1.1 16.1 6 1.2 12.2 6 1.4 11.2 6 0.4 5.7 6 0.8 6.0 6 0.4 12.7 6 2.9 13.0 6 2.5
18:1, n-7 — — 7.7 6 0.7 — 2.6 6 0.3 — 2.9 6 0.9 —
18:2, n-6 — — 25.0 6 3.2 35.4 6 2.1 — — — —
18:3, n-3 — — — — 42.3 6 3.3 58.5 6 4.7 — —
18:3, n-6 — — 7.9 6 2.2 — — — 13.2 6 3.6 19.2 6 3.5
18:4, n-3 — — — — 15.3 6 1.8 — — —
20:2, n-6 4.0 6 0.3 — 3.3 6 0.5 — — — — —
20:3, n-6 — — 1.7 6 0.2 — — — 9.8 6 1.8 —
20:3, n-3 — 5.8 6 0.5 — — 3.4 6 0.4 — — —
20:4, n-6 — — — — — — 0.8 6 0.2 —
20:4, n-3 — — — — 1.4 6 0.2 — — —
Percentage elongated
18:3, n-6 — — 17.7 — — — 44.5 —
18:4, n-3 — — — — 8.4 — — —
18:2, n-6 — — 8.7 — — — — —
18:3, n-3 — — — — 5.4 — — —
Fatty acid composition of yeast transformed with F56H11.4 and either the borage D6-fatty acid desaturase or the M. alpina D5-fatty acid desaturase. Exogenous
substrates were 18:3, n-6; 18:3, n-3 (D6); or 18:3, n-6 (D5). The D6-desaturase also was expressed alone in the presence of either 20:2, n-6 or 20:3, n-3 substrates.
The fatty acid compositions of transformed yeast were analyzed as described for Table 1.





























enzymes (such as FAE1) may indicate that several distinct forms
of this enzyme exist. There are at least seven ORFs related to
F56H11.4 present in the C. elegans genome, which may represent
other distinct (condensing) enzymes. Based on our data, these
different condensing enzyme activities might determine the
nature and substrate specificity of an elongase complex.
We also observed that F56H11.4 is in close proximity to a related
gene (F56H11.3; 51% similarity). The presence of related (but
distinct) enzymes involved in PUFA synthesis in close physical
proximity has been observed previously by our group in the case of
the C. elegans D5- and D6-fatty acid desaturases, which are less than
1 kilobase apart (5, 8, 12). That the D5- and D6-fatty acid desatu-
rases and the PUFA elongase both map to very similar regions of
chromosome IV (4.41, 4.42, and 4.32 centimorgans, respectively;
less than 300 kilobases apart) may also be of significance. It is also
clear that the PUFA elongating activity F56H11.4 and its proximal
partner (F56H11.3) contain two conserved intronyexon junctions;
similarly, the presence of conserved intronyexon junctions in the D5-
and D6-fatty acid desaturases has also been reported (12, 26). One
rationale for these presumptive gene-duplication events is that they
drive the evolution of new enzyme activities (as in the case of the
fatty acid desaturase).
In respect to the substrates used by the reconstituted PUFA
elongation activity, the underlying mechanisms that allow this
enzyme to elongate 18:3, n-6 (16:1, n-7), although they discriminate
against 18:2, n-6 and 18:3, n-3, remain to be elucidated. Also,
although the elongation of 16:1, n-7 was unexpected, this elongation
may account for the significant levels of 18:1, n-7 observed in C.
elegans (24). Nevertheless, it is clear that the fatty acid elongation
activity described in this study does display substrate preference.
Elongation of substrates such as 18:3, n-3 or 18:2, n-6 is less efficient
than that observed for 18:3, n-6. The efficiency of elongation for
tetraenoic fatty acid 18:4, n-3 is also twice that for 18:3, n-3,
although only slightly greater (35%) than that for 18:2, n-6. Thus,
the F56H11.4 enzyme recognizes a range of substrates commen-
surate with it having a major role in PUFA biosynthesis but displays
a clear preference for D6-desaturated (n-6 or n-3) C18 fatty acids.
This result is also in agreement with the reported profile of C.
elegans PUFAs (24).
The coexpression of the elongase with the D5- and D6-fatty acid
desaturases resulted in the production of C20 PUFAs, with both
20:4, n-6 and 20:5, n-3 being detected, although the latter was at
a lower level. Previously, Browse and coworkers (27) functionally
characterized a C. elegans v3-fatty acid desaturase with speci-
ficity for both C18 and C20 substrates that was capable of
producing 20:5, n-3 from 20:4, n-6. Thus, the biosynthetic
pathway for 20:5, n-3 could be via either a final methyl-directed
desaturation of 20:4 n-6 or the D5-desaturation of the 20:4, n-3
fatty acid.
Conclusions
We have isolated an enzymatic component of the C. elegans
elongase responsible for the synthesis of C20 PUFAs. This ORF
shows limited similarity to yeast genes required for medium-chain
(ELO1) and sphingolipid very long-chain (ELO2y3) saturated fatty
acid elongation but displays a high degree of substrate specificity for
C18 trienoic and tetraenoic fatty acids. It is likely that F56H11.4
encodes a condensing enzyme activity that interacts with endoge-
nous yeast enzyme components to reconstitute a functional elon-
gase.
Expression of the C. elegans fatty acid elongation activity in yeast
in conjunction with PUFA-specific fatty acid desaturases resulted in
the accumulation of trienoic, tetraenoic, and pentaenoic C20 fatty
acids from dienoic and trienoic C18 precursors. Thus, it is possible
to reconstitute this metabolic pathway in a heterologous host,
providing a biotechnological method for the synthesis of these
valuable compounds.
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Table 3. Fatty acid composition of yeast expressing C. elegans
ORF F56H11.4 and both fatty acid desaturases required for PUFA
biosynthesis
Fatty acid
mol percentage fatty acids
F56H11.4 1 D5 1 D6
18:2, n-6 18:3, n-3
1 2 1 2
16:0 19.1 6 0.9 22.8 6 1.3 17.1 6 0.9 21.8 6 0.3
16:1, n-7 17.2 6 0.6 23.4 6 0.3 5.2 6 0.8 10.6 6 0.9
16:2, n-7 0.4 6 0.2 — 0.2 6 0.1 —
18:0 4.2 6 0.1 5.1 6 0.1 5.6 6 0.5 5.4 6 0.1
18:1, n-9 12.8 6 1.5 10.5 6 0.7 6.0 6 0.8 6.3 6 0.6
18:1, n-7 8.0 6 1.7 — 2.5 6 0.8 —
18:2, n-6 25.8 6 2.1 38.2 6 1.6 — —
18:3, n-3 — — 47.6 6 3.4 55.9 6 1.4
18:3, n-6 6.8 6 1.4 — — —
18:4, n-3 — — 10.8 6 1.9 —
20:2, n-6 3.65 6 1.2 — — —
20:3, n-6 1.4 6 0.3 — — —
20:3, n-3 — — 3.4 6 0.2 —
20:4, n-6 0.25 6 0.1 — — —
20:4, n-3 — — 1.4 6 0.3 —
20:5, n-3 — — 0.2 6 0.1 —
Percentage elongated
18:3, n-6 19.5 — — —
18:4, n-3 — — 12.9 —
18:2, n-6 9.6 — — —
18:3, n-3 — — 5.4 —
Fatty acid composition of yeast cotransformed with F56H11.4 and both the D5-
andD6-fattyaciddesaturases;inductiontimewas96h.Either18:2,n-6or18:3,n-3was
supplied as exogenous substrates. Analysis was performed as described for Table 1.
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